Healthcare - Biotechnology - NASDAQ - US
$ 189.23
-2.1 %
$ 21 B
Market Cap
-23.08
P/E
Price Target
Average
54.66%
Revenue Forecast
Estimate
32.69%
EBIT
Estimate
--54.32%
Net Income
Estimate
31.95%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BeiGene, Ltd.
Wall Street analysts predict an average 1-year price target for BGNE of $293 , with forecasts ranging from a low of $283 to a high of $307 .
BGNE Lowest Price Target
Wall Street Target
283 USD
49.55%
BGNE Average Price Target
Wall Street Target
293 USD
54.66%
BGNE Highest Price Target
Wall Street Target
307 USD
62.24%
REVENUE FORECAST
Revenue Forecast Chart BGNE
EBIT FORECAST
EBIT Forecast Chart BGNE
NET INCOME FORECAST
Net Income Chart BGNE